Chitosan nanoparticles for the treatment of ischemia-reperfusion injury: mechanisms, preclinical evidence, challenges, and future perspectives

Yongxin Dong, Weidong Qiang

Open source

DOI
10.1080/1061186x.2026.2723295
Published
2026-09-03
Container
Journal of Drug Targeting
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/1061186x.2026.2723295,
  title = {Chitosan nanoparticles for the treatment of ischemia-reperfusion injury: mechanisms, preclinical evidence, challenges, and future perspectives},
  author = {Yongxin Dong and Weidong Qiang},
  year = {2026},
  journal = {Journal of Drug Targeting},
  doi = {10.1080/1061186x.2026.2723295},
  url = {https://doi.org/10.1080/1061186x.2026.2723295}
}

RIS

TY  - JOUR
TI  - Chitosan nanoparticles for the treatment of ischemia-reperfusion injury: mechanisms, preclinical evidence, challenges, and future perspectives
AU  - Yongxin Dong
AU  - Weidong Qiang
PY  - 2026
JO  - Journal of Drug Targeting
DO  - 10.1080/1061186x.2026.2723295
UR  - https://doi.org/10.1080/1061186x.2026.2723295
ER  - 

APA

Dong, Y., & Qiang, W. (2026). Chitosan nanoparticles for the treatment of ischemia-reperfusion injury: mechanisms, preclinical evidence, challenges, and future perspectives. Journal of Drug Targeting. https://doi.org/10.1080/1061186x.2026.2723295

Source records